Balanced news tone
News Sentiment
PHAL sentiment intelligence
PharmaLundensis AB news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
50
Balanced news tone
4 relevant articles
News tone and price action are not far from neutral.
80/100 classification confidence.
directly relevant articles
high-authority source matches
+0.0% over one week, +401.6% over four weeks, trend inactive, and below fair value.
Pharmalundensis has its final trading day on Spotlight today
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Primary event
Market update
80/100 classification
One-week reaction
0.0%
Price digesting
Trend fit
Trend inactive
401.6% over four weeks
Fair value
-33.5%
Below fair value
Market Dynamics buy signal
Value support
Sentiment Mix
Positive, neutral, negative
Positive
0
Neutral
4
Negative
0
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
marketscreener.com
Direct company coverage
Pharmalundensis has its final trading day on Spotlight today
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 Jul 2026 04:13
- Source
- marketscreener.com
marketscreener.com
Direct company coverage
Pharmalundensis to be delisted from Spotlight on July 14
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jul 2026 10:37
- Source
- marketscreener.com
marketscreener.com
Direct company coverage
EFN: Pharmalundensis CEO urged share purchases, sold shares himself
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 Jul 2026 07:11
- Source
- marketscreener.com
marketscreener.com
Direct company coverage
PharmaLundensis: Phal-501 said to bind heavy metals more effectively than IodoCarb
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 30 Jun 2026 07:00
- Source
- marketscreener.com